|
1
|
Araghi M, Soerjomataram I, Jenkins M,
Brierley J, Morris E, Bray F and Arnold M: Global trends in
colorectal cancer mortality: Projections to the year 2035. Int J
Cancer. 144:2992–3000. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
van Gijn W, Marijnen CA, Nagtegaal ID,
Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius
B and van de Velde CJ: Dutch Colorectal Cancer Group. Preoperative
radiotherapy combined with total mesorectal excision for resectable
rectal cancer: 12-year follow-up of the multicentre, randomised
controlled TME trial. Lancet Oncol. 12:575–582. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kye BH and Cho HM: Overview of radiation
therapy for treating rectal cancer. Ann Coloproctol. 30:165–174.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
No authors listed. News of Science.
Science. 125:18–22. 1957.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Brock KK, McShan DL, Ten Haken RK,
Hollister SJ, Dawson LA and Balter JM: Inclusion of organ
deformation in dose calculations. Med Phys. 30:290–295.
2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
De Ruysscher D, Belderbos J, Reymen B, van
Elmpt W, van Baardwijk A, Wanders R, Hoebers F, Vooijs M, Ollers M
and Lambin P: State of the art radiation therapy for lung cancer
2012: A glimpse of the future. Clin Lung Cancer. 14:89–95.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Emami B, Lyman J, Brown A, Coia L, Goitein
M, Munzenrider JE, Shank B, Solin LJ and Wesson M: Tolerance of
normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol
Phys. 21:109–122. 1991.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Marks LB, Yorke ED, Jackson A, Ten Haken
RK, Constine LS, Eisbruch A, Bentzen SM, Nam J and Deasy JO: Use of
normal tissue complication probability models in the clinic. Int J
Radiat Oncol Biol Phys. 76 (Suppl):S10–S19. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Baumann M, Krause M, Overgaard J, Debus J,
Bentzen SM, Daartz J, Richter C, Zips D and Bortfeld T: Radiation
oncology in the era of precision medicine. Nat Rev Cancer.
16:234–249. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tang L, Wei F, Wu Y, He Y, Shi L, Xiong F,
Gong Z, Guo C, Li X, Deng H, et al: Role of metabolism in cancer
cell radioresistance and radiosensitization methods. J Exp Clin
Cancer Res. 37(87)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen T, Zhang Y, Guo WH, Meng MB, Mo XM
and Lu Y: Effects of heterochromatin in colorectal cancer stem
cells on radiosensitivity. Chin J Cancer. 29:270–276.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Han YD, Kim WR, Park SW, Cho MS, Hur H,
Min BS, Baik SH, Lee KY and Kim NK: Predictors of pathologic
complete response in rectal cancer patients undergoing total
mesorectal excision after preoperative chemoradiation. Medicine
(Baltimore). 94(e1971)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Czochor JR and Glazer PM: microRNAs in
cancer cell response to ionizing radiation. Antioxid Redox Signal.
21:293–312. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bhat SA, Majid S and Hassan T: MicroRNAs
and its emerging role as breast cancer diagnostic marker - A
review. Adv Biomarker Sci Technol. 1:1–8. 2019.
|
|
19
|
Yu H, Guan Z, Cuk K, Zhang Y and Brenner
H: Circulating microRNA biomarkers for lung cancer detection in
East Asian populations. Cancers (Basel). 11(415)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Masuda T, Hayashi N, Kuroda Y, Ito S,
Eguchi H and Mimori K: MicroRNAs as biomarkers in colorectal
cancer. Cancers (Basel). 9(124)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen L, Wen Y, Zhang J, Sun W, Lui VWY,
Wei Y, Chen F and Wen W: Prediction of radiotherapy response with a
5-microRNA signature-based nomogram in head and neck squamous cell
carcinoma. Cancer Med. 7:726–735. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pasi F, Corbella F, Baio A, Capelli E, De
Silvestri A, Tinelli C and Nano R: Radiation-induced circulating
miRNA expression in blood of head and neck cancer patients. Radiat
Environ Biophys. 59:237–244. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Halimi M, Parsian H, Mohsen Asghari S,
Sariri R, Moslemi D and Yeganeh F: MicroRNAs: Are they indicators
for prediction of response to radiotherapy in breast cancer? Irn J
Med Hypotheses Ideas. 7:59–64. 2013.
|
|
24
|
Moertl S, Mutschelknaus L, Heider T and
Atkinson MJ: MicroRNAs as novel elements in personalized
radiotherapy. Transl Cancer Res. 5:S1262–S1269. 2016.
|
|
25
|
Fenech M: Cytokinesis-block micronucleus
cytome assay. Nat Protoc. 2:1084–1104. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ueno T, Monzen S, Chiba M, Morino Y and
Hosokawa Y: Screening for biological marker of dose-optimization in
cancer radiotherapy. Nippon Hoshasen Gijutsu Gakkai Zasshi.
74:459–464. 2018.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
27
|
Ueno T, Monzen S, Chiba M and Hosokawa Y:
Basic investigation to optimize radiation dose using biological
evaluation in radiotherapy. Cytometry Res. 28:7–11. 2018.
|
|
28
|
International Atomic Energy Agency:
Cytogenetic Dosimetry: Applications in Preparedness for and
Response to Radiation Emergencies. EPR-Biodosimetry 2011. Vienna,
2011.
|
|
29
|
Liu Q, Cao J, Wang ZQ, Bai YS, Lü YM,
Huang QL, Zhao WZ, Li J, Jiang LP, Tang WS, et al: Dose estimation
by chromosome aberration analysis and micronucleus assays in
victims accidentally exposed to (60)Co radiation. Br J Radiol.
82:1027–1032. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rodrigues G, Velker V and Best L:
Radiation Oncology Primer and Review, Essential Concepts and
Protocols. 1st edition. Demos MEDICAL, pp1-376, 2013.
|
|
31
|
Japanese Society for Radiation Oncology:
JASTRO Guidelines 2020 for Radiotherapy Treatment Planning. Fifth
edition. Kanehara & Co. Ltd., 2020. (In Japanese).
|
|
32
|
Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA,
Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin
D, et al: Radiation therapy for rectal cancer: Executive summary of
an ASTRO clinical practice guideline. Pract Radiat Oncol. 11:13–25.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Babel I, Barderas R, Díaz-Uriarte R,
Martínez-Torrecuadrada JL, Sánchez-Carbayo M and Casal JI:
Identification of tumor-associated autoantigens for the diagnosis
of colorectal cancer in serum using high density protein
microarrays. Mol Cell Proteomics. 8:2382–2395. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Oh T, Kim N, Moon Y, Kim MS, Hoehn BD,
Park CH, Kim TS, Kim NK, Chung HC and An S: Genome-wide
identification and validation of a novel methylation biomarker,
SDC2, for blood-based detection of colorectal cancer. J Mol Diagn.
15:498–507. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Han M, Liew CT, Zhang HW, Chao S, Zheng R,
Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, et al: Novel blood-based,
five-gene biomarker set for the detection of colorectal cancer.
Clin Cancer Res. 14:455–460. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang S, Xiang J, Li Z, Lu S, Hu J, Gao X,
Yu L, Wang L, Wang J, Wu Y, et al: A plasma microRNA panel for
early detection of colorectal cancer. Int J Cancer. 136:152–161.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Faltejskova P, Svoboda M, Srutova K,
Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K,
Kiss I, et al: Identification and functional screening of microRNAs
highly deregulated in colorectal cancer. J Cell Mol Med.
16:2655–2666. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wei WT, Nian XX, Wang SY, Jiao HL, Wang
YX, Xiao ZY, Yang RW, Ding YQ, Ye YP and Liao WT: miR-422a inhibits
cell proliferation in colorectal cancer by targeting AKT1 and
MAPK1. Cancer Cell Int. 17(91)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cui C, Yu J, Huang S, Zhu H and Huang Z:
Transcriptional regulation of gene expression by microRNAs as
endogenous decoys of transcription factors. Cell Physiol Biochem.
33:1698–1714. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Cui C, Zhai D, Cai L, Duan Q, Xie L and Yu
J: Long noncoding RNA HEIH promotes colorectal cancer tumorigenesis
via counteracting miR-939-mediated transcriptional repression of
Bcl-xL. Cancer Res Treat. 50:992–1008. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang N, He X, Zhou R, Jia G and Qiao Q:
STAT3 induces colorectal carcinoma progression through a novel
miR-572-MOAP-1 pathway. OncoTargets Ther. 11:3475–3484.
2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang M, Hu H, Wang Y, Huang Q, Huang R,
Chen Y, Ma T, Qiao T, Zhang Q, Wu H, et al: Long non-coding RNA
TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of
miR-197-3p in colorectal cancer. J Cancer. 10:4603–4613.
2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Della Vittoria Scarpati G, Falcetta F,
Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK,
D'Incalci M, De Placido S and Pepe S: A specific miRNA signature
correlates with complete pathological response to neoadjuvant
chemoradiotherapy in locally advanced rectal cancer. Int J Radiat
Oncol Biol Phys. 83:1113–1119. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gopalan V, Pillai S, Ebrahimi F,
Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA and Lam
AK: Regulation of microRNA-1288 in colorectal cancer: Altered
expression and its clinicopathological significance. Mol Carcinog.
53 (Suppl 1):E36–E44. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lu X and Lu J: The significance of
detection of serum miR-423-5p and miR-484 for diagnosis of
colorectal cancer. Clin Lab. 61:187–190. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLOS ONE. 9(e92921)2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015.PubMed/NCBI View Article : Google Scholar
|
